Plasma levels of annexins IV and V in relation to antiphospholipid antibody status in women with a history of recurrent miscarriage

Thrombosis Research

Volumn 120, Issue 6, 2007, Pages 865-870

  Ulander, Veli Matti ^a   Stefanovic, Vedran ^a   Masuda, Junko ^b   Suzuki, Kimihiro ^c   Hiilesmaa, Vilho ^a   Kaaja, Risto ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 4; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT ABORTION; SPONTANEOUS ABORTION; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; ANNEXIN A4; ANNEXIN A5; ANTIBODIES, ANTIPHOSPHOLIPID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; THROMBOPHILIA;

EID: 34548685228     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.01.010     Document Type: Article

References (23)

1. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
2. Dudding T.E., and Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 91 (2004) 700-711
3. Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D., et al. The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
4. de Groot P.G., and Derksen R.H. Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 3 (2005) 1854-1860
5. Rand J.H., Wu X.X., Andree H.A., Lockwood C.J., Guller S., Scher J., et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 337 (1997) 154-160
6. Masuda J., Takayama E., Satoh A., Ida M., Shinohara T., Kojima-Aikawa K., et al. Levels of annexin IV and V in the plasma of pregnant and postpartum women. Thromb Haemost 91 (2004) 1129-1136
7. Bank I., Libourel E.J., Middeldorp S., Hamulyak K., van Pampus E.C., Koopman M.M., et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost 3 (2005) 79-84
8. Vaarala O., Alftan G., Jauhiainen M., Leirisalo-Repo M., Aho K., and Palosuo T. Cross reaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341 (1993) 923-925
9. Puurunen M., Vaarala O., Julkunen H., Aho K., and Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 80 (1996) 16-22
10. Wang X., Campos B., Kaetzel J.R., and Dedman J.R. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 180 (1999) 1008-1016
11. Bonet B., Brunzell J.D., Gown A.M., and Knopp R.H. Metabolism of very-low-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. Metabolism 41 (1992) 596-603
12. Krikun G., Lockwood C.J., Wu X.X., Zhou X.D., Guller S., Calandri C., et al. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 15 (1994) 601-612
13. Kaburaki J., Kuwana M., Yamamoto M., Kawai S., and Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 54 (1997) 209-213
14. Matsuda J., Saitoh N., Gohchi K., Gotoh M., and Tsukamoto M. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 47 (1994) 56-58
15. Matsuda J., Gotoh M., Saitoh N., Gohchi K., Tsukamoto M., and Yamamoto T. Anti-annexin V antibodies in the sera of patients with habitual fetal loss or preeclampsia. Thromb Haemost 75 (1994) 105-106
16. Di Simone N., Castellani R., Caliandro D., and Caruso A. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 65 (2001) 1766-1770
17. Rand J.H., Wu X.X., Guller S., Gil J., Guha A., Scher J., et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 171 (1994) 1566-1572
18. Rand J.H., Wu X.X., Lapinski R., van Heerde W.L., Reutelingsperger C.P., Chen P.P., et al. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 104 (2004) 2783-2790
19. Van Heerde W.L., Reutelingsperger C.P., Maassen C., Lux P., Derksen R.H., and De Groot P.G. The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma. J Thromb Haemost 1 (2003) 532-536
20. Rand J.H., Arslan A.A., Wu X.X., Wein R., Mulholland J., Shah M., et al. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 194 (2006) 182-188
21. Satoh A., Takayama E., Kojima K., Ogawa H., Katsura Y., Kina T., et al. Modulation of cell surface lectin receptors on K562 human erythroleukemia cells induced by transfection with annexin IV cDNA. FEBS Lett 405 (1997) 107-110
22. Satoh A., Takayama E., Kojima K., Ogawa H., Yamori T., Sato S., et al. Expression of carbohydrate-binding protein p33/41 in human tumor cell lines. J Biochem (Tokyo) 119 (1996) 346-353
23. Bizzaro N., Antico A., Musso M., Platzgummer S., Camogliano L., Tozzoli R., et al. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss. Ann N Y Acad Sci 1050 (2005) 348-356